CTRI/2013/12/004252
招募中
未知
A Study to Evaluate the Prevalence of Hypogonadism in Indian Males with Type 2 Diabetes Mellitus (DM).
MSD Pharmaceuticals Pvt Ltd0 个研究点目标入组 897 人待定
概览
- 阶段
- 未知
- 干预措施
- 未指定
- 疾病 / 适应症
- Health Condition 1: null- Indian Males with Type 2 Diabetes Mellitus who may or may not be suffering with Hypogonadism.
- 发起方
- MSD Pharmaceuticals Pvt Ltd
- 入组人数
- 897
- 状态
- 招募中
- 最后更新
- 4年前
概览
简要总结
暂无简介。
研究者
入排标准
入选标准
- •1\.Males between the age of 30 to 59 years (both inclusive), with a confirmed diagnosis of Type\-2 diabetes mellitus
- •2\.Each subject must be willing to provide written informed consent
排除标准
- •1\.Type 1 diabetes patients
- •2\.Patients receiving testosterone replacement therapy
- •3\.Patients suffering from any chronic liver disease, renal disease, advanced malignancy, debilitating diseases like tuberculosis, malabsorption, inflammatory bowel disease, pyrexia of unknown origin, AIDS, sickle cell disease, autoimmune diseases like rheumatoid arthritis, ankylosing spondylitis
- •4\.Patients with known causes of hypogonadism including:
- •o Hypergonadotropic hypogonadism or primary hypogonadism: testicular failure due to genetic disorders (e.g., Klinefelterâ??s syndrome), orchitis, trauma, castration, radiation, chemotherapy, or undescended testes
- •o Hypogonadotropic hypogonadism, central hypogonadism, or secondary hypogonadism: patients with gonadotropin deficiency or dysfunction as a result of disease or damage to the hypothalamic\-pituitary axis (e.g. Kallmannâ??s syndrome, tumour, trauma, radiation, sarcoidosis, or tuberculosis).
- •5\.Patients on medications, or have taken medications in last 6 months, known to cause hypogonadal states like ketoconazole, anabolic steroids, corticosteroids, spironolactone, cimetidine, phenytoin, GnRH analogue, flutamide and narcotic addicts (heroin).
- •6\.Patients having severe psychological symptoms
- •7\.Patients currently enrolled in another clinical trial
- •8\.Patients having any clinically significant condition or situation, other than the condition being studied that, in the opinion of the Investigator, would interfere with the study evaluations or optimal participation in the study.
结局指标
主要结局
未指定
相似试验
尚未招募
不适用
A study on the relationship between hypogonadism and endocrine dysfunction, osteoporosis and lipodystrophy in men with HIV infectioKCT0003118Keimyung University Dongsan Medical Center50
招募中
不适用
SEXUAL PROBLEMS IN DIABETIC PATIENTSHealth Condition 1: null- Type 2 Diabetes MellitusCTRI/2013/05/003608DR DEEPAK C 100
已完成
不适用
Symptoms and Clinical Signs of Hypogonadism in Testicular Cancer SurvivorsMetabolic SyndromeHypogonadismCardio-vascular DiseaseNCT02240966Rigshospitalet, Denmark200
尚未招募
不适用
How common is sexual dysfunction among female Lupus Nephritis patients? A study on its prevalence and related factors.CTRI/2024/05/068027Arpana Limbu
终止
不适用
Prevalence of Secondary Hypogonadism in Male Patients on Chronic Opioid Therapy for Cancer-Related Pain SyndromesAdvanced CancerHypogonadismPainNCT00529230M.D. Anderson Cancer Center46